Article
FOXM1 drives HPV+ HNSCC sensitivity to WEE1 inhibition
22 Oct 2020
Abstract excerpt
Head and neck squamous cell carcinoma (HNSCC) associated with high-risk human papilloma virus (HPV) infection is a growing clinical problem. The WEE1 kinase inhibitor AZD1775 (WEE1i) overrides cell cycle checkpoints and is being studied in HNSCC regimens. We show that the HPV16 E6/E7 oncoproteins sensitize HNSCC cells to single-agent WEE1i treatment through activation of a FOXM1-CDK1 circuit that drives mitotic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
